# A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects

> **NCT02675309** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MT-8554
- **DRUG:** rosuvastatin
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT02675309
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675309, "A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02675309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*